In the latest session, Sotera Health Co (NASDAQ: SHC) closed at $14.95 down -13.75% from its previous closing price of $17.34. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 5487898 shares were traded.
Ratios:
For a deeper understanding of Sotera Health Co’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 5.24 whereas as Long-Term Debt/Eq ratio is at 5.20.
On June 26, 2023, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $24.
JP Morgan Upgraded its Underweight to Neutral on January 23, 2023, whereas the target price for the stock was revised from $6 to $18.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4.23B and an Enterprise Value of 6.15B. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 83.22, and their Forward P/E ratio for the next fiscal year is 16.58. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.03 while its Price-to-Book (P/B) ratio in mrq is 9.53. Its current Enterprise Value per Revenue stands at 5.86 whereas that against EBITDA is 19.66.
Stock Price History:
Over the past 52 weeks, SHC has reached a high of $19.40, while it has fallen to a 52-week low of $12.34. The 50-Day Moving Average of the stock is 15.90, while the 200-Day Moving Average is calculated to be 15.55.
Shares Statistics:
For the past three months, SHC has traded an average of 744.92K shares per day and 1.25M over the past ten days. A total of 282.83M shares are outstanding, with a floating share count of 98.40M. Insiders hold about 65.18% of the company’s shares, while institutions hold 28.67% stake in the company. Shares short for SHC as of Feb 15, 2024 were 12.02M with a Short Ratio of 16.13, compared to 9.74M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.25% and a Short% of Float of 12.08%.
Earnings Estimates
There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.15 for the current quarter, with a high estimate of $0.21 and a low estimate of $0.11, while EPS last year was $0.13. The consensus estimate for the next quarter is $0.2, with high estimates of $0.25 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.91 and $0.7 for the fiscal current year, implying an average EPS of $0.8. EPS for the following year is $0.95, with 6 analysts recommending between $1.05 and $0.82.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $253.5M this quarter.It ranges from a high estimate of $277.91M to a low estimate of $234.8M. As of the current estimate, Sotera Health Co’s year-ago sales were $220.59M, an estimated increase of 14.90% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $275.17M, an increase of 7.80% less than the figure of $14.90% in the same quarter last year. There is a high estimate of $285.45M for the next quarter, whereas the lowest estimate is $268.5M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.12B, while the lowest revenue estimate was $1.08B, resulting in an average revenue estimate of $1.1B. In the same quarter a year ago, actual revenue was $1.05B, up 4.60% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.2B and the low estimate is $1.16B. The average revenue growth estimate for next year is up 7.40% from the average revenue estimate for this year.
